Skip to content
value.today

Affinity Biosensors LLC

Total raised
$65 M
13 rounds on record
Latest round
$5 M
Mar 2026
First round on record
Dec 2013
Today
Private
No later event on record

Funding rounds

13 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Affinity Biosensors LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$5 MNo. 13$2 to $10 million

Affinity Biosensors LLC: Raise no. 13, Mar 2026

Investors in this round

1 investor had bought by the notice of Oct 14, 2026: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: SAFE
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer · Chief Executive Officer and Manager
  • Charles Mamrak · Director · Manager
  • Jeffrey Hawkins · Director · Manager
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Ceo. Source: SEC Form D and 3 amendments, newest notice filed Oct 14, 2026. Read the notice at the SEC.

equitySEC
Nov 2024$14 MNo. 12$10 to $50 million

Affinity Biosensors LLC: Raise no. 12, Nov 2024

Investors in this round

27 investors had bought by the notice of Dec 26, 2024: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $15 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them, other: Series A-5A Units and Series A-5B Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · CEO
  • Michael Pfau · Executive Officer · Secretary
  • James Iuliano · Director
  • L. Robert Johnson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Dec 26, 2024. Read the notice at the SEC.

equitySEC
Jun 2024$4 MNo. 11$2 to $10 million

Affinity Biosensors LLC: Raise no. 11, Jun 2024

Investors in this round

27 investors had bought by the notice of Jun 12, 2024: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Simple Agreement for Future Equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director
  • Michael E. Pfau · Executive Officer · Secretary
  • James Iuliano · Director
  • L. Robert Johnson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 12, 2024. Read the notice at the SEC.

equity, optionsSEC
Nov 2023$2 MNo. 10$2 to $10 million

Affinity Biosensors LLC: Raise no. 10, Nov 2023

Investors in this round

12 investors had bought by the notice of Mar 22, 2024: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-4 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Chief Executive Officer and Manager
  • Michael E. Pfau · Executive Officer · Secretary
  • James Iuliano · Director · Manager
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 22, 2024. Read the notice at the SEC.

equitySEC
Jul 2023$4 MNo. 9$2 to $10 million

Affinity Biosensors LLC: Raise no. 9, Jul 2023

Investors in this round

17 investors had bought by the notice of Oct 10, 2023: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-4 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Chief Executive Officer and Manager
  • Michael E. Pfau · Executive Officer · Secretary
  • James Iuliano · Director · Manager
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 10, 2023. Read the notice at the SEC.

equitySEC
Nov 2022$4 MNo. 8$2 to $10 million

Affinity Biosensors LLC: Raise no. 8, Nov 2022

Investors in this round

15 investors had bought by the notice of Feb 17, 2023: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-4 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Chief Executive Officer and Manager
  • Michael E. Pfau · Executive Officer · Secretary
  • James Iuliano · Director · Manager
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 17, 2023. Read the notice at the SEC.

equitySEC
Nov 2021$5 MNo. 7$2 to $10 million

Affinity Biosensors LLC: Raise no. 7, Nov 2021

Investors in this round

21 investors had bought by the notice of Nov 17, 2021: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-4 preferred units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Manager and Chief Executive Officer
  • Michael Pfau · Executive Officer · Secretary
  • James Iuliano · Director · Manager
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Ceo. Source: SEC Form D, newest notice filed Nov 17, 2021. Read the notice at the SEC.

equitySEC
Nov 2020$4 MNo. 6$2 to $10 million

Affinity Biosensors LLC: Raise no. 6, Nov 2020

Investors in this round

21 investors had bought by the notice of Nov 4, 2020: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-4 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Chief Executive Officer and Manager
  • Michael Pfau · Executive Officer · Secretary
  • James Iuliano · Director · Manager
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Ceo. Source: SEC Form D, newest notice filed Nov 4, 2020. Read the notice at the SEC.

equitySEC
Aug 2019$6 MNo. 5$2 to $10 million

Affinity Biosensors LLC: Raise no. 5, Aug 2019

Investors in this round

1 investor had bought by the notice of Feb 3, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $10 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-3 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Manager and Chief Executive Officer
  • L. Robert Johnson · Executive Officer, Director · Manager and Chief Financial Officer
  • Michael Pfau · Executive Officer · Secretary
  • James Iuliano · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Feb 3, 2020. Read the notice at the SEC.

equitySEC
Nov 2017$5 MNo. 4$2 to $10 million

Affinity Biosensors LLC: Raise no. 4, Nov 2017

Investors in this round

1 investor had bought by the notice of Dec 17, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $7 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-2 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Chief Executive Officer and Manager
  • Michael Pfau · Executive Officer · Secretary
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 2 amendments, newest notice filed Dec 17, 2018. Read the notice at the SEC.

equitySEC
Jun 2016$7 MNo. 3$2 to $10 million

Affinity Biosensors LLC: Raise no. 3, Jun 2016

Investors in this round

9 investors had bought by the notice of Aug 23, 2016: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-2 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Manager and Chief Executive Officer
  • Scott Manalis · Executive Officer, Director · Manager and Secretary
  • L. Robert Johnson · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kenneth Babcock, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Aug 23, 2016. Read the notice at the SEC.

equitySEC
Jan 2015$3 MNo. 2$2 to $10 million

Affinity Biosensors LLC: Raise no. 2, Jan 2015

Investors in this round

17 investors had bought by the notice of Feb 9, 2015: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A-2 Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer, Director · Manager and Chief Executive Officer
  • Scott Manalis · Executive Officer, Director · Manager and Secretary

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds used for working capital.”

Signed by Kenneth Babcock, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Feb 9, 2015. Read the notice at the SEC.

equitySEC
Dec 2013$1 MNo. 1Under $2 million

Affinity Biosensors LLC: Raise no. 1, Dec 2013

Investors in this round

17 investors had bought by the notice of Dec 23, 2013: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Units
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in California

People named in the notice

  • Kenneth Babcock · Executive Officer · Manager and President

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds to be used for working capital”

Signed by Kenneth Babcock, President. Source: SEC Form D, newest notice filed Dec 23, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Affinity Biosensors LLC chose not to state its revenue in its newest notice of a funding round (Oct 2026).

    SEC Form D · Oct 2026

  • The industry group it chose in its notices: Other.

    SEC Form D · Oct 2026

That is all the official record says: Affinity Biosensors LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Affinity Biosensors LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 13 rounds above had up to 27 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Affinity Biosensors LLC
NameRoleNamed in
Kenneth BabcockChief Executive Officer and ManagerSep 2026
Michael PfauSecretaryDec 2024
Michael E. PfauSecretaryJun 2024
L. Robert JohnsonManager and Chief Financial OfficerFeb 2020
Scott ManalisManager and SecretaryAug 2016
Charles MamrakManagerSep 2026
Jeffrey HawkinsManagerSep 2026
L. Robert JohnsonManagerSep 2026
James IulianoDirectorDec 2024
Kenneth BabcockCEODec 2024
Scott ManalisManager and SecretaryAug 2016